Do different delivery systems of hormone therapy have different effects on psychological symptoms in surgically menopausal women? A randomized controlled trial

Maturitas

Volumn 62, Issue 2, 2009, Pages 140-145

  Baksu, Basak ^a   Baksu, Alparslan ^a   Göker, Nimet ^a   Citak, S ^b  

^a SISLI ETFAL TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b Bakirkoy Hospital for Psychiatric and Neurological Diseases   (Turkey)

Author keywords

Anxiety; Climacteric symptoms; Depression; Hormonal therapy; Menopause

Indexed keywords

CONJUGATED ESTROGEN; ESTRADIOL; ESTREVA; FOLLITROPIN; UNCLASSIFIED DRUG;

ADULT; ANXIETY DISORDER; ARTHRALGIA; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ESTRADIOL BLOOD LEVEL; ESTROGEN THERAPY; FEMALE; FOLLITROPIN BLOOD LEVEL; GEL; HAMILTON ANXIETY SCALE; HAMILTON SCALE; HEADACHE; HEART PALPITATION; HOT FLUSH; HUMAN; INSOMNIA; INVOLUTIONAL DEPRESSION; MAJOR CLINICAL STUDY; MELANCHOLIA; MENOPAUSAL SYNDROME; MENOPAUSE; MYALGIA; NERVOUSNESS; PARESTHESIA; PROSPECTIVE STUDY; PSYCHOLOGICAL ASPECT; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SURGICAL PATIENT; TREATMENT DURATION; TREATMENT OUTCOME; VAGINAL PRURITUS; VERTIGO; WEAKNESS;

ADMINISTRATION, CUTANEOUS; ADMINISTRATION, INTRANASAL; ADMINISTRATION, ORAL; ADULT; ANXIETY; DEPRESSION; ESTRADIOL; ESTROGENS, CONJUGATED (USP); FEMALE; FOLLICLE STIMULATING HORMONE; HUMANS; MIDDLE AGED; POSTMENOPAUSE;

EID: 60749134371     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2008.12.010     Document Type: Article

References (33)

1. Sherwin B.B. Impact of the changing hormonal milieu on psychological functioning. In: Lobo Ra. (Ed). Treatment of the postmenopausal woman: basic and clinical aspects (1994), Raven Press, New York 119-127
2. Shively C.A., and Bethea C.L. Cognition, mood disorders, and sex hormones. ILAR J 45 (2004) 189-199
3. Cohen L.S., Soares C.N., and Joffe H. Diagnosis and management of mood disorders during the menopausal transition. Am J Med 118 Suppl. 12B (2005) 935-975
4. Schmidt P.J. Depression; the perimenopause, and estrogen therapy. Ann N Y Acad Sci 1052 (2005) 27-40
5. Wieck A. Ovarian hormones, mood and neurotransmitters. Int Rev Psychiatry 8 (1996) 17-25
6. Taylor M. Psychological consequences of surgical menopause. J Reprod Med 46 (2001) 317-324
7. Sherwin B.B. The impact of different doses of estrogen and progestin on mood and sexual behaviour in postmenopausal women. J Clin Endocrinol Metabol 72 (1991) 336-343
8. Rasgon N.L., Altshuler L.L., Fairbanks L.A., et al. Estrogen replacement therapy in the treatment of major depressive disorder in perimenopausal women. J Clin Psychiatry 63 Suppl. 7 (2002) 45-48
9. Kuppermann K.I., Blatt M.H.G., Wiesbader H., and Filler W. Comparative clinical evaluation of estrogenic preparations by the menopausal and amenorrheal indices. J Clin Endocrinol 13 (1953) 688-703
10. Williams B.W. A structural interview guide for Hamilton Depression Rating Scale. Arch Gen Psychiatry 45 (1978) 742-747
11. Akdemir A., Turkcapar H., Orsel S.D., Gerigergi N., Dag I., and Ozbay M.H. Reliability and validity of the Turkish version of the Hamilton Depression Rating Scale. Compr Psychiatry 42 (2001) 161-165
12. Per Bech. The Bech, Hamilton and Zung scales for mood disorders: screening and listening. 2nd ed. (1996), Springer, New York
13. Yazici M.K., Demir B., Tanriverdi N., Karacaoglu E., and Yolac P. The study testing of the validity and reliability of Hamilton Anxiety Rating Scale. Turk J Psychiatr 9 (1998) 114-117
14. Grigoriadis S., and Kennedy S.H. Role of estrogen treatment of depression. Am J Therapeutics 9 (2002) 503-509
15. Zweifel J.E., and O'Brien W.H. A meta-analysis of the effect of hormone replacement therapy upon depressed mood. Psychoneuroendocrinology 22 (1997) 189-212
16. Soares C.N., Almeida O.P., Joffe H., and Cohen L.S. Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women: a double-blind, randomized, placebo-controlled trial. Arch Gen Psychiatry 58 (2001) 529-534
17. Pearce M.J., and Hawton K. Psychological and sexual aspects of the menopause and HRT. Baillieres Clin Obstet Gynecol 10 (1996) 385-399
18. Heinrich A.B., and Wolf O.T. Investigating the effects of estradiol or estradiol/progesterone treatment on mood, depressive symptoms, menopausal symptoms and subjective sleep quality in older healthy hysterectomized women: a questionnaire study. Neuropsychobiology 52 (2005) 17-23
19. Sagsoz N., Oguzturk O., Bayram M., and Kamaci M. Anxiety and depression before and after the menopause. Arch Gynecol Obstet 264 (2001) 199-202
20. Kraemer G.R., Kraemer R.R., Ogden B.W., Kilpatrick R.E., Gimpel T.L., and Castracane D. Variability of serum estrogens among postmenopausal women treated with the same transdermal estrogen therapy and the effect of androgens and sex hormone binding globulin. Fertil Steril 79 (2003) 534-542
21. Gregoire A.J.P., Kumar R., Everitt B., et al. Transdermal estrogen for treatment for severe postnatal depression. Lancet 47 (1996) 930-933
22. Baksu A., Ayas B., Citak S., Kalan A., Baksu B., and Goker N. Efficacy of tibolone and transdermal estrogen therapy on psychological symptoms in women following surgical menopause. Int J Obstet Gynecol 91 (2005) 58-62
23. Pearce J., Hawton K., and Blake F. Psychological effects of estrogen implant therapy: a placebo-controlled trial. J Psychosom Res 42 (1997) 177-186
24. Saletu B., Brandstatter N., Metka M., et al. Hormonal, syndromal and EEG mapping studies in menopausal syndrome patients with and without depressions compared with control. Maturitas 23 (1996) 91-105
25. Foidart J.M., Beliard A., Hedon B., et al. Impact of percutaneous estradiol gel in postmenopausal hormone replacement therapy on clinical symptoms and endometrium. Br J Obstet Gynecol 104 (1997) 305-310
26. Archer D.F., and EstroGel Study Group. Percutaneous 17-beta-estradiol gel for the treatment of vasomotor symptoms in postmenopausal women. Menopause 10 (2003) 516-521
27. Naunton M., Al Hadithy A.F., Brouwers J.R., and Archer D.F. Estradiol gel: review of the pharmacology, pharmacokinetics, efficacy, and safety in menopausal women. Menopause 13 (2006) 517-527
28. Yonkers K.A., Bradshaw K., and Halbreich U. Estrogens, progestins and mood. In: Steiner M., Yonkers K.A., and Ericson E. (Eds). Mood disorders in women (2000), Martin Dunitz, London 207-232
29. Palacios S. Pulsed estrogen therapy relieving climacteric symptoms, preventing bone loss. Climacteric 5 Suppl. 2 (2002) 32-39
30. Davis S.R., Davisson S.L., Wilson S., Shepherd J., and Lawton B. Intranasal versus transdermal matrix estrogen replacement in Australian women. Maturitas 51 (2005) 163-171
31. Nielsen T.F., Raun P., Pitkin J., and Christiansen C. Pulsed estrogen therapy improves postmenopausal quality of life: a 2-year placebo-controlled study. Maturitas 53 (2006) 184-190
32. Pearlstein T., Rosen K., and Stone A.B. Mood disorders and menopause. Endocrinol Metab Clin North Am 26 (1997) 279-294
33. Birkhauser M. Depression, menopause and estrogens: is there a correlation?. Maturitas 41 Suppl. 1 (2002) S4-S8